Table 2 HTA reports of biosimilars by organisations, countries of origin and type of reports
From: Health technology assessment of biosimilars worldwide: a scoping review
HTA organisation | Country of HTA organisation | Full-HTA (n = 2) | Mini-HTA (n = 4) | Rapid reviews (n = 64) |
|---|---|---|---|---|
HAS | France | 0 | 0 | 31 |
CADTH | Canada | 0 | 3 | 9 |
INESSS | Canada | 1 | 1 | 7 |
NIHR HC | United Kingdom | 0 | 0 | 3 |
NICE | United Kingdom | 1 | 0 | 1 |
RER | Italy | 0 | 0 | 4 |
Veneto CRUF | Italy | 0 | 0 | 1 |
AQuaAS | Spain | 0 | 0 | 2 |
TLV | Sweden | 0 | 0 | 1 |
AHTAPol | Poland | 0 | 0 | 1 |
ACE | Singapore | 0 | 0 | 2 |
ICER | United States | 0 | 0 | 1 |
IECS | Argentine | 0 | 0 | 1 |